Cargando…
The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour
Background Glucagon-like peptide-1 receptor agonists (GLP-1 RA) added to insulin in type 2 diabetes patients have shown to lower body weight, improve glycaemic control and reduce total daily insulin dose in short term studies, although the individual response greatly varies. Objective To evaluate GL...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733138/ https://www.ncbi.nlm.nih.gov/pubmed/26597956 http://dx.doi.org/10.1007/s11096-015-0219-8 |